source
- Sionna Therapeutics to lay off 46% of staff after cystic fibrosis trial setbackSionna Therapeutics announced it will cut 46% of its workforce following an unexpected failure in its cystic fibrosis trial. The company, which employed about 59 people, said roughly 27 employees…
- Rare disease reform, CMC risk, reshoring US trials top of mind ahead of PDUFA VIII meetingThe FDA gathers Wednesday to hear what industry stakeholders and the public want included in the latest iteration of the Prescription Drug User Fee Act that sets the agency’s priorities for fiscal…